503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
View analysts' price targets and recommendations, and compare them with competitors.
$601.38
Analysts expect the stock price to increase by 17.94%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
91.58B
The estimated revenue has decreased from the previous period.
19.80B
The estimated EBITDA has decreased from the previous period.
2.67
The estimated EPS has increased from the previous period.
9.54B
The estimated net income has decreased from the previous period.
13.83B
The estimated EBIT has decreased from the previous period.
17.04B
The estimated SG&A expenses have decreased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
539.11B
Revenue has increased from the previous period.
13.86%
Revenue growth rate has decreased from the previous period.
282.42B
EBITDA has increased from the previous period.
52.39%
EBITDA margin has increased from the previous period.
237.14B
EBIT has increased from the previous period.
43.99%
EBIT margin has increased from the previous period.
45.29B
Depreciation has increased from the previous period.
266.54B
Total cash has decreased from the previous period.
49.44%
Cash percentage has decreased from the previous period.
125.04B
Receivables have increased from the previous period.
23.19%
Receivables percentage has increased from the previous period.
5.90B
Inventories have decreased from the previous period.
1.10%
Inventory percentage has decreased from the previous period.
49.55B
Accounts payable has increased from the previous period.
9.19%
Payables percentage has increased from the previous period.
-84.79B
Capital expenditure has increased from the previous period.
-15.73%
CapEx percentage has increased from the previous period.
8.56%
WACC has increased from the previous period.
8.65%
Cost of equity has increased from the previous period.
3.94%
Cost of debt has decreased from the previous period.
1.03
Beta has increased from the previous period.
7.46B
Diluted shares outstanding has decreased from the previous period.
60.59B
Total debt has decreased from the previous period.
3.91T
Total equity has increased from the previous period.
3.97T
Total capital has increased from the previous period.
1.52%
Debt weighting has decreased from the previous period.
98.48%
Equity weighting has increased from the previous period.
198.35B
EBIAT has increased from the previous period.
148.94B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
3.39T
Terminal value has increased from the previous period.
2.70T
Enterprise value has increased from the previous period.
30.35B
Net debt has decreased from the previous period.
2.67T
Equity value has increased from the previous period.
357.74
Equity value per share has increased from the previous period.
